NIAID bars U.S. disease scientists from communicating with the WHO during active outbreaks

In a May 18, 2026 email to staff, a senior official at the National Institute of Allergy and Infectious Diseases instructed that U.S. infectious-disease researchers could participate in World Health Organization virtual meetings only in small groups of no more than three people and only in a "listening capacity." Any "legitimate research questions or countermeasure testing ideas" had to be routed "through the proper chain of command," and follow-up to WHO meetings would be handled by NIAID's parent agency, the Department of Health and Human Services. The email was obtained by CNN, which reported the policy on May 25.

The restriction took effect while the WHO was coordinating responses to active Ebola and Hantavirus outbreaks — exactly the circumstances in which direct, real-time exchange among the world's infectious-disease scientists is most consequential. Current and former U.S. health officials described barring scientist-to-scientist coordination during an emerging public-health emergency as unprecedented, and noted that the constraint arrived amid significant leadership vacancies across the federal health agencies, including at NIAID, the FDA, and the CDC.

Confining federal scientists to a "listening capacity" and channeling all substantive scientific communication with the WHO through a political chain of command at HHS suppresses the government's own public-health research output and degrades outbreak-response capacity at a moment when international coordination matters most. The directive functions simultaneously as a gag on agency scientists, a suppression of the government's contribution to shared disease data, and a hollowing-out of NIAID's operational role in global health emergencies.